# A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies

> **NCT00210977** · — · WITHDRAWN · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.**

## Conditions studied

- Anemia

## Interventions

- **DRUG:** No intervention

## Key facts

- **NCT ID:** NCT00210977
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-12
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study never started due to zero enrolment
- **Last updated:** 2013-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00210977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00210977, "A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00210977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*